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Langerinþ Dermal DC, but Not Langerhans Cells,
Are Required for Effective CD8-Mediated Immune
Responses after Skin Scarification with Vaccinia
Virus
Julien Seneschal1,2, Xiaodong Jiang1 and Thomas S. Kupper1
Skin scarification (s.s.) with vaccinia virus (VACV) is essential for generation of an optimal protective T-cell
memory immune response. Dendritic cells (DCs), which are professional antigen-presenting cells, are required
for naive T-cell priming and activation. At least three subsets of skin-resident DC have been identified:
Langerhans cells (LCs), dermal Langerinþ DC (LangþdDC), and dermal Langerin– DC (Lang–dDC). Using
Langerin-diphtheria toxin receptor mice and established mouse model of VACV delivered by s.s., we
demonstrated that LangþdDC, but not LC, are absolutely required for the induction of a rapid and robust
antigen-specific CD8þ T-cell response after s.s. with VACV. The depletion of LangþdDC led to a significant delay
in the priming and proliferation of antigen-specific CD8þ T cells. Moreover, CD8þ T cells generated after
VACV s.s. in the absence of LangþdDC lacked effector cytotoxic functions both in vitro and in vivo. While
s.s.-immunized wild-type and LC-depleted mice controlled the progression of OVA257–264 expressing T-cell
lymphoma EG7 (injected intradermally), the depletion of LangþdDC led to rapid lymphoma progression and
mortality. These data indicate that of all skin DC subsets, LangþdDC is the most critical for the generation of
robust CD8þ T-cell immunity after s.s. with VACV.
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INTRODUCTION
Vaccinia virus (VACV) immunization provides complete pro-
tection against Variola major, the causative agent of smallpox,
and a vaccination campaign based on this strategy led to the
worldwide eradication of smallpox disease (Hammarlund
et al., 2003; Stewart and Devlin, 2006). We have observed
that protection against VACV is more closely associated with a
protective T-cell immune response, rather than neutralizing
antibody production (Liu et al., 2010). More specifically,
CD8þ T cells, many of them tissue-resident memory cells
(TRM) have a pivotal role in controlling VACV infections (Jiang
et al., 2012). In mice and human, immunization with VACV
results in an acute infection that elicits strong and efficient
development of cytotoxic CD8þ T cells response. Moreover,
we have previously shown that the mode of vaccine delivery
is very important in the induction of a robust immune respo-
nse against VACV. We have demonstrated that immunization
through the skin via skin scarification (s.s.), rather than
conventional vaccine injection routes as subcutaneous or
intramuscular, is most effective for the generation of the
strong T-cell–mediated immune response (Liu et al., 2010).
T-cell priming, activation, and proliferation are dependent
upon professional antigen-presenting cells (APCs) such as
dendritic cells (DCs). In mice, blood-derived conventional
DC can be divided in two subsets: CD8aþ DC and CD8a
DC. The CD8a DC were then classified into CD4þ and
CD4 DC populations (Vremec et al., 2000; Heath and
Carbone, 2009). The lymph nodes (LNs) contain also a
subset of migrating DC. In skin-draining LNs, three subsets
of migrating DC can be defined: Langerhans cells (LC),
dermal Langerinþ DC (LangþdDC), and dermal Langerin
DC (LangdDC; Bursch et al., 2007; Ginhoux et al., 2007;
Poulin et al., 2007). It is now clear that in mice models, LC
are unable to generate CD8þ T-cell immunity to viral
infection, especially to herpes simplex virus type 1 (HSV-1)
after infection of the skin epidermis (Allan et al., 2003; Bedoui
et al., 2009). Moreover, in constitutive and inducible LC-
deficient mice models, LC appeared to be largely dispensable
for contact hypersensitivity sensitization, and may actually
generate tolerance and dampen inflammation (Kaplan et al.,
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2005; Igyarto et al., 2009; Bobr et al., 2010). Since the
discovery of bone marrow–derived skin LangþdDC, extensive
studies evaluated the role of this DC subset for antigen
presentation and for the generation of immune response
during infection or inflammation. It has been suggested that
LangþdDC contribute to immune responses against HSV
(Bedoui et al., 2009), leishmania major (Brewig et al., 2009),
or those generated after contact hypersensitivity reactions
(Kaplan et al., 2008). However, the relative role of these
subsets of skin-resident DC in the induction of immune
response after s.s. with VACV remains unknown.
In this study, we investigated the role of LC and LangþdDC
in cross-priming responses to VACV inoculated by s.s. in
transgenic mice expressing the diphtheria toxin receptor under
the control of the murine Langerin promoter (Lang-DTR)
mouse model (Kissenpfennig et al., 2005). As shown
previously, the systemic administration of diphtheria toxin
(DT) depletes LC, and repopulation is delayed for several
weeks, whereas LangþdDC are replenished within a few days
(Bursch et al., 2007). Taking advantage of this model, we
selectively depleted either LC alone or both LC and Langþ
DC. Then, using recombinant VACV that expressed the
ovalbumin peptide OVA257–264 (rVACV-ova) and adoptive
transfer of OVA257–264-specific CD8
þ T cells from OT-I TCR
transgenic mice, we demonstrated that LangþdDC are
required for the induction of a rapid and robust antigen-
specific CD8þ T cells immunity after s.s. against vaccinia
virus. The depletion of LC alone had no discernable effect on
immunity after s.s. However, the depletion of LangþDC as
well led to a significant delay in the priming and proliferation
of antigen-specific CD8þ T cells. Moreover, CD8þ T cells
generated after VACV s.s. in the absence of LangþdDC lacked
effector cytotoxic functions both in in vitro and in vivo.
Although s.s.-immunized wild-type (WT) and LC-depleted
mice control, the progression of the OVA257–264 expressing
T-cell lymphoma EG7 (injected intradermally), the depletion
of LangþdDC led to more rapid lymphoma progression and
mortality. These data suggest of all skin DC subsets, only
LangþdDC are critical for the generation of robust protective
CD8þ T-cell immunity after s.s. with VACV.
RESULTS
LangþdDC are required for efficient activation and proliferation
of antigen-specific CD8þ T cells in draining LN after VACV
immunization via s.s.
To compare the activation and proliferation of antigen-specific
CD8þ T cells after VACV immunization via s.s., we first
treated Lang-DTR mice with systemic DT 13 days before
immunization (LC-depleted group) or 13 days, 1 day before
immunization and then every 48 hours (LangþDC-depleted
group). WT C57Bl/6 recipient mice were also treated with
systemic administration of DT as a control (Figure 1a). As
shown in Supplementary Figure S1 online, LangþDC are not
affected by DT injection in WT mice. After one single
injection of DT 13 days before immunization, LCs are still
absent of the epidermis and LangþdDC are replenished but at
a lower level compared with WT group, whereas LangþDC
are totally absent when DT injection is injected 13 days and
1 day before immunization. We then adoptively transferred
carboxy-fluorescein diacetate succinimidyl ester (CFSE)-
labeled Th1.1þ naive CD8þ T cells isolated from OT-I TCR
transgenic mice 24 hours prior rVACV-ova immunization via
s.s. At days 3, 5, and 7, skin-draining inguinal LNs (ILNs), were
harvested and analyzed for OT-I cell proliferation (Figure 1b).
As previously shown (Liu et al., 2006), high proliferation of
OT-I harvested from WT mice group was detected in ILN that
drained the scarified infected site. In LC-depleted group,
proliferation of OT-I cells was comparable to WT, while in
LangþDC-depleted group, proliferation of OT-I mice was
significantly reduced at days 3, 5, and 7. However, some
activated OT-I cells were detected at day 7 in ILN from
LangþDC-depleted mice group. Moreover, no significant
proliferation were found in LN draining others tissues in all
mice groups, although a small number of dividing OT-I cells
were also found in spleen in control group (Supplementary
Figure S2 online). These data suggest that LangþdDC are
required for a rapid and robust priming and proliferation of
antigen-specific CD8þ T cells in skin-draining LNs after s.s.
immunization against VACV. In additional experiments, to
analyze the capacity to cross-present rVACV-ova of each
subsets of DC early after immunization, we used a sorting
scheme of DC previously described (Henri et al., 2010),
allowing the isolation of populations of CD207 (EGFP)þ
CD103þ dDC, CD207 (EGFP)þ CD103 fraction that
comprises the majority of murine LC (mLC) and a small
fraction of CD207 (EGFP)þ CD103 dDC and CD207
(EGFP) CD103 DC and LN-resident DC in cutaneous
LN, 48 hours after immunization with rVACV-ova. As shown
in Supplementary Figure S3 online, each subset were then
incubated in vitro with purified CFSE-labeled OT-I cells and
OT-I proliferation was then assessed by flow cytometry,
showing that CD207(EGFP)þ CD103þ dDC were the major
DC population capable of cross-presentation, in an early
phase of immunization compared with others skin DC
populations showing minimal or absence of ability for cross-
presentation.
The absence of LangþdDC delays and reduces the infiltration of
antigen-specific CD8þ T cells in infected skin
Having shown that LangþdDC are required for early activa-
tion and proliferation of antigen-specific CD8þ T cells in skin-
draining LN after s.s. infection with VACV, we asked whether
the absence of LangþdDC can also affect the infiltration of T
cells in infected skin at different time point (days 3 and 7). Skin
s.s. infected tails from WT group, LC-depleted group, and
LangþDC-depleted group, were harvested. T cells were
extracted from tail skin and analyzed by flow cytometry.
Activated OT-I cells were significantly reduced in LangþDC-
depleted group when compared with WT and LC-depleted
group (Figure 2a and b). We next analyzed the expression of
homing molecules: E-Lig and P-Lig on T cells using E-selectin/
Fc or P-selectin/Fc chimeric molecules, on OT-I cells in ILN
after s.s. In both WT and the LC-depleted group proliferating
OT-I cells showed an upregulation of skin-homing molecules
in ILN of s.s.-infected mice (Figure 2c and d). In the absence of
LangþDC, the activation and proliferation of OT-I cells
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decreased dramatically, but the small fraction of T cells
undergoing proliferation in the LangþDC-depleted group
expressed E-Lig and P-Lig at the same level than WT and
LC-depleted groups. Altogether our data demonstrate that
LangþdDC are required for the effective early activation and
proliferation of antigen-specific T cells in skin-draining LN
after immunization via s.s., they do not appear to affect the
expression of skin-homing receptors once antigen-specific
CD8þ T cells become activated.
In the absence of LangþdDC, OT-I cells do not acquire effector
functions
Having shown that absence of LangþdDC decreases and
delays the activation and proliferation of antigen-specific
CD8þ T cells after immunization via s.s., we wished to
determine whether OT-I cells could acquire effector functions
despite of the depletion of LangþdDC. WT mice group (DT-
13, -1 and every 48 hours), LC-depleted group (DT-13) and
LangþDC-depleted group (DT-13, -1 and every 48 hours)
were immunized with rVACV-ova via s.s. 1 day after adoptive
transfer of CFSE-labeled OT-I cells. On days 3 and 7 after
immunization, skin-draining ILNs and spleen cells were
harvested and re-stimulated in vitro with 1mM OVA257–264 in
the presence of Brefeldin. IFN-g production was then analyzed
using flow cytometry. Proliferating OT-I T cells in WT and LC-
depleted group produced high amount of IFN-g in skin-
draining ILN and spleen at days 3 and 7. In contrast, in the
absence of LangþDC, the percentage of OT-I-producing IFN-g
was significantly reduced in the early phase of T cells
activation in contrast to latter activation (Figure 3a and b).
CD8þ T cells effector functions are not only measured by
the production of IFN-g, but also by their cytotoxic activity
in vitro. In order to test this function, we set up a cytolysis
assay. Mice from the WT group, LC-depleted group, and
LangþDC-depleted group were immunized with rVACV-ova
after adoptive transfer of OT-I cells. On day 5, OT-I cells from
skin-draining ILNs were harvested by positive selection. EG7
cells were used as target cells. Target cells were labeled with
PKH-26 according to the manufacturer’s instructions and then
with CFSE and dispensed into plates. OT-I cells isolated from
LN at day 5 after s.s. immunization were added at different
ratios and mixed with target cells for 5 hours before analysis.
In vitro generated effector OT-I cells and naive OT-I cells were
used as positive and negative control, respectively. After
5 hours of incubation, dilution of CFSE on PKH-26þ target
cells was analyzed by flow cytometry. Cytotoxic activity was
lower in the presence of OT-I isolated from LangþDC-
depleted group whereas cytotoxic activity was high in the
presence of OT-I harvested from WT and LC-depleted groups
(Figure 4). These data suggest that LangþdDC are required for
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Figure 1. CD8þ T cells activation was delayed in the absence of dermal Langerinþ DC (LangþdDC) after tail skin scarification (s.s.) with rVACV-ova.
Carboxy-fluorescein diacetate succinimidyl ester (CFSE)-labeled naive Thy1.1þ OT-I cells were transferred into Thy1.2þ B6 or in Thy1.2þ Lang-DTR mice.
(a) Recipient Lang-DTR mice were treated with DT 13 days only (Langerhans cell (LC)-depleted group) or 13 days, 1 day before rVV-ova immunization and then
every 48 hours (LangþDC-depleted group). Wild-type (WT) C57BL/6 mice were also treated with DT as the LangþDC-depleted group. Recipient mice were then
infected with rVACV-ova by s.s. (b) Proliferation of OT-I cells in inguinal lymph node (ILN) was analyzed at days 3, 5, and 7 by flow cytometry. Histograms
were gated on Thy1.1þCD8þ OT-I donor and are representative of four independent experiments. DT, diphtheria toxin; rVV, recombinant vaccinia virus;
VACV, vaccinia virus.
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Figure 2. Recruitment of OT-I cells to the infected skin site is less efficient in the absence of dermal Langerinþ DC (LangþdDC) after skin scarification (s.s.)
with vaccinia virus (VACV). Carboxy-fluorescein diacetate succinimidyl ester (CFSE)-labeled naive Thy1.1þ OT-I cells were transferred into Thy1.2þ C57BL/6 or
in Thy1.2þ Lang-DTR mice. Recipient Lang-DTR mice were treated with DT 13 days only (Langerhans cell (LC)-depleted group) or 13 days, 1 day before rVACV-
ova immunization and then every 48 hours (LangþDC-depleted group). Wild-type (WT) C57BL/6 mice were also treated with DT as the LangþDC-depleted group.
At 24 hours after OT-I transfer, recipient mice were infected with rVACV-ova by s.s. OT-I cells were isolated from infected skin at various time points (days 3 and
7). (a) Numbers in quadrant indicate percentage of Thy1.1þ for one representative mouse. (b) Percentage of Thy1.1þ cells in infected skin. The graph shows
means±SD. Data are representative of three independent experiments; **Pp0.01. (c) E-Lig and P-Lig expression was examined by incubating cells from inguinal
lymph node (ILN) with rmCD62E/Fc or rmCD62P/Fc chimera in Hank’s balanced salt solution (HBSS) buffer containing 2 mM calcium at days 3 and 7. HBSS buffer
supplemented with 5 mM EDTA was used for the controls. Data are representative of three independent experiments. (d) Percentage of E-Ligþ and P-Ligþ cells in
the proliferating cells. The graph shows means±SD. Data are representative of three independent experiments. FCS, fetal calf serum; NS, not significant.
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the induction of a strong effector cytotoxic CD8þ T-cell
immune response after immunization via s.s.
LangþdDC modulate tumor immunity induced by immunization
via s.s.
Our data demonstrate that LangþdDC modulate the develop-
ment of the strong effector/cytotoxic CD8þ T cells immune
response against VACV after s.s. that we have observed
previously (Jiang et al, 2012). Our previous study showed
that immunization with VACV via s.s. is more effective than
other routes of immunization to protect mice against tumor
challenge (Liu et al., 2010). We asked whether LangþdDC
could impair the effective protection of s.s. route in terms of
tumor protection. WT group, LC-depleted (DT-13), and
LangþDC-depleted group (DT-13, -1, every 72 hours) were
immunized with rVV-ova via s.s. and then challenged with
EG7 tumor cells intradermally on the same day. In WT mice,
tumors became palpable 5–8 days after challenge in the
untreated group, and subsequent tumor growth was rapid
(Figure 5a and b). In WT mice immunized with VACV-ova,
tumor growth was significantly retarded and was negligible
even at 25 days. The LC-depleted group showed results
indistinguishable from the WT group. In contrast, LangþDC-
depleted group developed early palpable tumors which, over
time, grew to a large size at day 18 (Supplementary Figure S4
online) and which grew rapidly thereafter and experienced
rapid mortality (Supplementary Figure S5 online). Thus, all
immunized mice developed some tumor immunity, although
depleted of both LC and LangþdDC developed tumor immu-
nity that was less robust. These data indicate that LangþdDC
represent a subset of DC important for an efficient tumor
immune response after s.s. immunization, but also suggest that
other Lang-DC have a significant role in tumor immunity.
DISCUSSION
Immunization through the skin using VACV delivered by s.s.
effectively eradicated Variola major infection worldwide. We
have recently observed that this remarkable efficacy was more
closely associated with the delivery mode of immunization
using superficially injured skin (i.e., s.s.), rather than immu-
nogenicity of the virus per se (Liu et al., 2010). We have
demonstrated that immunization via s.s. using VACV is highly
effective to induce antigen-specific T-cell response, protecting
mice against VACV infection independently of neutralizing
antibody production. Moreover, mice previously immunized
via s.s. with a recombinant VV loaded with tumor antigen
were better protected against tumor challenge in skin than
mice immunized via conventional routes. However, the
precise mechanism by which immunization through
epidermis is so remarkably effective remains unknown. This
study rules out epidermal LC as contributing to this efficacy.
Immunization using skin disruption mobilizes a large number
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Figure 3. OT-I effector response is impaired in the absence of dermal Langerinþ DC (LangþdDC) after skin scarification (s.s.) with rVACV-ova. Carboxy-
fluorescein diacetate succinimidyl ester (CFSE)-labeled naive Thy1.1þ OT-I cells were transferred into Thy1.2þ C57BL/6 or in Thy1.2þ Lang-DTR mice. Recipient
Lang-DTR mice were treated with DT 13 days before immunization (Langerhans cell (LC)-depleted group), or 13 days, 1 day before immunization, and then every
48 hours (LangþDC-depleted group). Wild-type (WT) C57BL/6 mice were also treated as the LangþDC-depleted group. Recipient mice were then s.s. immunized
with rVACV-ova. (a) At days 3 and 7, cells from inguinal lymph node (ILN) and spleen were isolated and re-stimulated in vitro with OVA257-264 peptide for
6 hours and analyzed for intracellular IFN-g. Cells were gated on Thy1.1þCD8þ OT-I cells. Numbers in quadrant indicate percentage of cells. (b) Percentage of
IFN-gþ OT-I cells in ILN and spleen. The graph shows means±SD. Data are representative of three independent experiments. **Pp0.01. NS, not significant;
VACV, vaccinia virus.
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of skin-resident DC (Steinman, 2008; Romani et al., 2010;
Sparber et al., 2010). Migrating DC to skin-draining LNs are
required to prime the specific T-cell immune response. It is
now well accepted that poxvirus infection through s.s. results
in a response highly dependent on cross-presentation (Shen
et al., 2002) and our present data suggest that a specific subset
of skin-resident DC, the LangþdDC are required for the
induction of an early activation and proliferation of antigen-
specific effector CD8 T-cell after VACV immunization through
the skin. Cross-priming has been studied in systems where DC
are not themself infected. In the case of VACV, infection of DC
can occur but is known to be abortive, leading to expression
of a subset of early genes but absolutely no late viral genes,
particularly ones required to viral assembly and replication
(Jenne et al., 2000; Chahroudi et al., 2006). Infected DC are
subject to apoptosis, supporting an immune response against
VACV through cross-presentation of exogenous viral antigens
acquired by uninfected DC from dying cells, as well as
from ambient late gene products released by apoptotic
keratinocytes. Moreover, it has been recently shown in a
mouse model of VACV infection that cross-priming of virus-
specific T cells was mediated through the expression of a DC-
restricted receptor DNGR-1 (also known as CLEC9A C-type
lectin domain family 9 memba A) (Iborra et al., 2012).
Mouse skin-resident DC sub-populations consist at least of
three different DC subsets: LC, LangdDC, and the Langþ
dDC. LangþdDC were recently discovered in 2007 as a
LangþDC population distinct from LC (Bursch et al., 2007;
Ginhoux et al., 2007; Poulin et al., 2007). Since this time,
research focused to define the role of these different skin-
resident DC sub-populations in the generation of immune
response.
In this study, we combined the advantages of two different
models: the murine VACV vaccination model developed in
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Figure 4. Dermal LangerinþDC (LangþdDC) are required to induce a strong
specific cytotoxic activity in vitro. Naive Thy1.1þ OT-I cells were transferred
into Thy1.2þ C57BL/6 or in Thy1.2þ Lang-DTR mice. Recipient Lang-DTR
mice were treated with DT 13 days only (Langerhans cell (LC)-depleted group)
or 13 days, 1 day before rVACV-ova immunization and then every 48 hours
(LangþDC-depleted group). Wild-type (WT) C57BL/6 mice were also treated
with DT as the LangþDC-depleted group. Recipient mice were then skin
scarification (s.s.) immunized with rVACV-ova. At day 5 after immunization,
spleen and skin-draining lymph nodes were harvested and OT-I cells were
isolated. Effector OT-I were generated in vitro and used as positive control.
Naive OT-I cells were used as a negative control. OT-I cells were then cultured
with target cells (EG7) stained with PKH-26 and carboxy-fluorescein diacetate
succinimidyl ester (CFSE) during 4 hours at various ratios in triplicate. Cytolysis
was analyzed by the dilution of CFSE on PKH-26þ cells using flow cytometry.
Each data point represent means±SD. Data are representative of two
independent experiments. **Pp0.01. VACV, vaccinia virus.
1,800
1,600
1,400
1,200
1,000
800
600
400
200
0
0 5 10 15 20 25
Days
Tu
m
o
r 
vo
lu
m
e 
(m
m3
)
Tu
m
o
r 
vo
lu
m
e 
(m
m3
)
WT control
WT VV-ova s.s.
DTR-Lang DT-13
DTR-Lang DT-13, -1,
every 48 hours
WT control
WT VV-ova s.s.
DTR-Lang DT-13
DTR-Lang DT-13, -1,
every 48 hours
3,000
2,500
2,000
1,500
1,000
500
0
10 15 20 30
Days
**
**
***
*
*
NS NS
NS
NS
a
b
Figure 5. Dermal LangerinþDC (LangþdDC) are required for efficient
protection provided by skin scarification (s.s.) with rVACV against tumor
challenge. Lang-DTR mice were treated with DT 13 days (Langerhans cell (LC)-
depleted group) or 13 days, 1 day before immunization and then every
72 hours (LangþDC-depleted group). C57BL/6 wild-type (WT) mice were
treated with DT as the LangþDC-depleted group. Mice were then s.s.
immunized with rVACV-ova. The same day mice were challenged with EG7
(5 106 cells per mouse) intradermally, and monitored for tumor growth (a, b)
Each data point represents the mean tumor volume of different groups (n¼8).
Data are the pooled results of two independent experiments. *Pp0.05,
**Pp0.01, ***Pp0.005. DT, diplhtheria toxin; NS, not significant; VACV,
vaccinia virus.
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our laboratory (Liu et al., 2006) and the Lang-DTR mice
allowing the selective depletion of LC and/or LangþDC, in
order to define the precise role of resident skin DC in the
induction of the early phase of T-cell immune response after
VACV immunization. We first observed that the depletion of
LangþdDC inhibited the early activation and proliferation of
antigen-specific CD8þ T-cell in the skin-draining LN and
LangþdDC appear as the only DC population to cross-present
virus in the early phase of immunization. Moreover, in the
absence of LangþdDC, the generation of CD8þ T-cell effector
function was also impaired as measured by production of
IFN-g and in their functional in vitro cytotoxic activity. These
data are consistent with findings observed in the literature for
other antigens. Recently, after subcutaneous infection with
leishmania major, Langþ non-LC were found to be the major
subset of skin migratory DC to induce CD8þ T-cell activation
(Brewig et al., 2009). Later studies using HSV-1 model have
found that LangþdDC contribute to the generation of HSV-1-
specific cytotoxic T lymphocyte immunity during the second
phase of HSV infection (Bedoui et al., 2009). However, in this
study, we still observed a late activation and proliferation of
antigen-specific T cells despite the total absence of LangþDC.
It is well documented that the LN-resident CD8aþ DC can
also have an active role in CD8þ T immunity. LN-resident
CD8aþ DC can capture antigen from migratory DC or from
material draining directly through the lymphatic conduits
(Heath and Carbone, 2009). Another hypothesis could be the
influx of blood-derived DC that can migrate to tissue anytime,
there is inflammation whether sterile or infectious. We have
previously shown that blood-derived DC constitutively express
high level of E-selectin and P-selectin ligand leading to their
ability for skin migration (Robert et al., 1999). Moreover, it has
been previously shown (Eidsmo et al., 2009) in HSV skin
infection model that blood-derived DC can migrate to infected
skin at a latter time by day 5. These newly recruited DC might
serve as new APCs to continue T-cell activation.
Another point of our observation is that antigen-specific
CD8þ T-cell migration to skin is reduced in the absence of
LangþdDC. At day 7 after immunization, we found in the
LangþDC-depleted mice, reduced percentage of CD8þ T
cells in infected skin when compared with the WT group and
LC-depleted group. However, despite the late activation of
effector CD8þ T cells occurring in the absence of Langþ
dDC, these CD8þ T cells still expressed skin-homing recep-
tors when they undergo proliferation in the skin-draining LN
at the same level as control groups. The absence of Langþ
dDC delays the generation of a specific effector T-cell
response but does not impair skin-homing imprinting when
CD8þ T cells become activated. The defect of migration
observed in our study results from a defect of T cells
proliferation but is not due to a defect of skin imprinting.
These findings are consistent with our previous results
suggesting that homing-imprinting program can be acquired
by activated T cells circulating through the tissue-draining LN
microenvironments (stromal cells, tissue-specific DC) inde-
pendent of antigen presentation (Liu et al., 2006).
A persistent question is the precise role of LC in the
generation of immune response. LC have long been accepted
in the literature to be the most powerful DC subset for T-cell
priming (Merad et al., 2008). This postulate has been
challenged since the discovery of LangþdDC as a distinct
DC subset from LC (Bursch et al., 2007; Poulin et al., 2007).
Data using LC-deficient mouse models indicated that LC
mediate immune tolerance, especially in contact hyper-
sensitivity reactions or more generally are not required for
the generation of effector T cells response against a variety of
antigens (Kaplan et al., 2005; Igyarto et al., 2009; Kaplan,
2010; Zahner et al., 2011). Other recent data from human
samples suggest that LC function to induce proliferation of
regulatory T cells, or Treg cells (Seneschal et al., 2012).
However, recent observations indicate that LC are capable
to induce Th17 responses especially against extracellular
pathogens in a infection model (Igyarto et al., 2011).
However, it is less clear that LC could induce cross-
presentation. Our present data did not show significant
differences between the LC-depleted groups and the WT
groups in any of the in vitro or in vivo assays we performed.
We can conclude that LC are dispensable for CD8þ T-cell
priming against VACV, compared with LangþdDC. However,
it is also notable that eliminating the LC population did not
enhance the activation and the proliferation of CD8þ T cells,
and we could not demonstrate in the VACV model any
immunoregulatory role of LC. These results may be due to
technical issues: LC-depleted mice group were intraperitone-
ally injected with DT 13 days before the beginning of the
experiment. Although epidermal LC completely absent from
skin after 13 days, the LangþdDC population has partially but
not completely been restored in the dermis. However, the
diminished number of LangþdDC in our Lang-DTR mice 13
days after DT injection could explain the absence of exag-
gerated immune response in the LC-depleted mice group.
Another hypothesis could be the functional impairment that
occurs during early repopulation of LangþdDC, leading to the
reduction of their proinflammatory capacity as previously
suggested (Kaplan, 2010). Our study does not distinguish
between these possibilities.
Finally, our in vitro was extended in vivo in an antigen-
specific tumor challenge model. Although s.s.-immunized WT
and LC-depleted mice controlled the progression of OVA
expressing T-cell lymphoma injected intradermally, the deple-
tion of LangþDC led to eventual lymphoma progression and
mortality. However, tumor growth was still significantly
delayed in these mice, suggesting a role for LangDC and
LN-resident DC. In conclusion, our present data indicate that
of all skin-resident DC subsets, LnþdDC are critical for the
generation of robust CD8þ T-cell immunity to infection after
s.s. with VACV.
MATERIALS AND METHODS
Mice, viruses, and viral infection
All animal work in compliance with the guidelines set out by the
Center for Animal Resources and Comparative Medicine at Harvard
Medical School (HMS), Boston, MA. Six- to 8-week-old female wt
C57BL/6, Lang-DTR, Lang-EGFP, and Thy1.1þ OT-I Rag1 / mice
were bred in a biosafety level 1 facility at HMS. rVACV-ova were kind
gifts from Dr Bernard Moss (National Institutes of Health, Bethesda,
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MD). The virus stocks were expanded and titered in Hela cells
and CV-1 cells (American Tissue Culture Company, ATCC, Manassas,
VA) by standard procedures. Mice were infected with the virus by s.s.
(2 106 plaque-forming unit in 5ml of phosphate-buffered saline). For
scarification, mice were anesthetized intraperitoneally with 2, 2, 2
tribromoethanol (250 mg kg–1, Sigma-Aldrich, St Louis, MO). In all,
5ml of diluted virus was applied to tail skin 1 cm from the base of the
tail. The skin area was gently scratched 25 times with a 28 ½ G
needle.
Chimeras, antibodies, and flow cytometry
Directly conjugated mAbs Thy1.1-PerCP (OX7), CD8a-PECy7 (53-
6.7), IFN-g-APC (XMG1.2), MHC class II-biotin (AF6-120.1), CD11b-
APC (M1/70), CD19-PE (1D3), and PerCP streptavidin were pur-
chased from BD Biosciences (San Jose, CA). rmE-selectin/Fc chimera
and rmP-selectin/Fc chimera were purchased from R&D Systems
(Minneapolis, MN). Data were acquired on six-color flow cytometer
and analyzed.
Adoptive transfer of OT-I cells
Spleens and LNs were harvested from 3- to 4-week-old Thy1.1þ OT-I
Rag1–/– mice. Red blood cells were lysed and single-cell suspension
was prepared. CD8þ T cells were isolated with the mouse CD8aþ
T-cell isolation kit according to the manufacturer’s protocol (Miltenyi
Biotech, Auburn, CA). The purity of the isolated cells was 495%
measured by flow cytometry. Before CFSE staining, cells were washed
twice with cold phosphate-buffered saline and incubated at 10
106 cells ml–1 in phosphate-buffered saline with 2mM CFSE (Life
Technologies, Grand Island, NY) at 37 1C for 3 minutes. Cells were
then washed twice with cold DMEM/10% fetal calf serum (FCS). In
all, 2 106 OT-I cells were injected intravenously in Thy1.2þ
recipient mice.
In vivo depletion of LC or of Langþ dDC
For systemic in vivo depletion of Langþ dDC, Lang-DTR mice were
injected intraperitoneally with 1mg DT (Sigma-Aldrich) using the
specified timing of administration. For some in vivo experiments,
mice were injected intraperitoneally with 20 ng g–1 DT.
Intracellular staining
Ex vivo intracellular cytokine staining, cells were cultured at 37 1C for
6 hours in complete medium supplemented with 1.0mg ml–1 of
Monensin (GolgiStop BD Pharmingen), in either the presence or the
absence of OVA257–264 peptide at 1.0mg ml
–1. Cells were then labeled
for surface epitopes and then were fixed and permeabilized using
Cytofix/Cytoperm kit (BD Biosciences) before staining for intracellular
markers according to the manufacturer’s instructions.
Detection of T cells in skin tissue
Skin samples were harvested from the base of the tails at different
times after rVACV-ova vaccinia challenge. Skin tail was incubated in
Hank’s balanced salt solution containing 1 mg ml–1 collagenase A and
40mg ml–1 DNase I (Roche Diagnostics, Indianapolis, IN) at 37 1C for
2 hours. Hank’s balanced salt solution containing 2 mM EDTA and 5%
FCS was then added to stop the digestion. Single-cell suspension was
prepared by passing cells through 70-mm cell strainers. Cells were
then stained with appropriate antibodies and analyzed by flow
cytometry.
CD62E and P analysis
To detect E-Lig and P-Lig expression, nonspecific binding to Fc
receptors was blocked by anti-mouse CD16/CD32. Cells then were
incubated with 5mg ml–1 of rmCD62E/Fc chimera or rmCD62P/Fc
chimera in Hank’s balanced salt solution supplemented with 2 mM
calcium, 5% FCS and 1 mM Hepes buffer at 4 1C for 30 minutes. After
washing, cells were incubated with APC anti-hFc-IgG at 4 1C for an
additional 30 minutes. Hank’s balanced salt solution buffer supple-
mented with 5 mM EDTA instead of calcium was used as control.
Cytotoxicity assay
OT-I cytotoxic T lymphocyte used as a positive control were
generated as described previously. Briefly, OT-I splenocytes
(1 106 per well) in 24-well plates containing 1 ml of RPMI 1640,
10% FCS and penicillin/streptomycin solution (conditioned medium),
containing OVA257-264 (1 nM), IL-4 (175 U ml
–1 R&D System), IL-2
(50 U ml–1). After 3 days in culture, the cells were washed and re-
cultured at 0.5 106 cells per well in 24-well plates containing 1 ml
of conditioned medium without OVA257–264, but with the same
cytokines that were present during initial culture. After an additional
2 days in culture, the cells were harvested and used as effector cells.
Naive OT-I were used as a negative control. At day 5 after
immunization with rVACV-ova, cells were isolated from spleen and
skin-draining LNs. Single-cell suspension was prepared by passing
cells through 70-mm cell strainers. Red blood cells were lysed and
then OT-I were isolated by using CD90.1 microbeads isolation kit
(Miltenyi Biotec) according to the manufacturer’s instructions.
In all, 2 103 target cells (EG7: an OVA gene-transfected EL4
thymoma cell line ATCC) were successively stained with PKH-26
(Sigma; final concentration 2.5 106 M) and then with 2mM CFSE as
previously described. Target cells were then co-cultured with effector
cells at various T:E ratio (1:25, 1:50, 1:100, 1:150) during 4 hours in a
96-well U-bottom plates (Becton Dickinson, Franklin Lakes, NJ) at
37 1C, 5% CO2. Then cells were fixed and analyzed by flow
cytometry within 24 hours for CFSE dilution.
Tumor challenge
EG7 cells were maintained in DMEM supplemented with 10% heat-
inactivated FCS, penicillin/streptomycin solution, and 400mg ml–1
G-418 (Life Technologies). C57BL/6 or Lang-DTREGFP mice were
intradermally challenged in the lower back with 5 106 EG7 cells.
The longest diameter (L) and the perpendicular diameter (W) of the
local tumor were measured with calipers at the indicated time
points. Tumor volumes were calculated using the formula Volume
¼ L2W/2.
Statistics
The differences in the means between groups were compared using a
one-tailed Student’s test. Pp0.05 was considered statistically significant.
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